Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) is one of 73 publicly-traded companies in the “Electromedical equipment” industry, but how does it weigh in compared to its rivals? We will compare Guided Therapeutics to related companies based on the strength of its profitability, dividends, risk, valuation, earnings, analyst recommendations and institutional ownership.
Analyst Recommendations
This is a breakdown of recent ratings for Guided Therapeutics and its rivals, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Guided Therapeutics | 0 | 0 | 0 | 0 | N/A |
Guided Therapeutics Competitors | 259 | 783 | 1961 | 109 | 2.62 |
As a group, “Electromedical equipment” companies have a potential upside of 3,151.19%. Given Guided Therapeutics’ rivals higher possible upside, analysts plainly believe Guided Therapeutics has less favorable growth aspects than its rivals.
Volatility & Risk
Earnings & Valuation
This table compares Guided Therapeutics and its rivals revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Guided Therapeutics | $100,000.00 | -$3.49 million | -5.83 |
Guided Therapeutics Competitors | $1.06 billion | $91.80 million | -7.37 |
Guided Therapeutics’ rivals have higher revenue and earnings than Guided Therapeutics. Guided Therapeutics is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Guided Therapeutics and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Guided Therapeutics | N/A | N/A | -138.23% |
Guided Therapeutics Competitors | -340.10% | -93.85% | -30.25% |
Insider & Institutional Ownership
9.7% of Guided Therapeutics shares are owned by institutional investors. Comparatively, 43.7% of shares of all “Electromedical equipment” companies are owned by institutional investors. 66.8% of Guided Therapeutics shares are owned by insiders. Comparatively, 14.7% of shares of all “Electromedical equipment” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
Guided Therapeutics rivals beat Guided Therapeutics on 6 of the 10 factors compared.
About Guided Therapeutics
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.